Flexion Therapeutics Probability of Future Stock Price Finishing Over 27.42
Flexion Therapeutics' future price is the expected price of Flexion Therapeutics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Flexion Therapeutics performance during a given time horizon utilizing its historical volatility. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
Please specify Flexion Therapeutics' target price for which you would like Flexion Therapeutics odds to be computed.
Flexion |
Flexion Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Flexion Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Flexion Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Flexion Therapeutics is not yet fully synchronised with the market data | |
| Flexion Therapeutics has some characteristics of a very speculative penny stock | |
| Flexion Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 102.74 M. Net Loss for the year was (95.05 M) with profit before overhead, payroll, taxes, and interest of 66.53 M. | |
| Flexion Therapeutics currently holds about 131.43 M in cash with (59.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.61. | |
| Over 92.0% of the company shares are owned by institutional investors |
Flexion Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Flexion Stock often depends not only on the future outlook of the current and potential Flexion Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Flexion Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Shares Percent Shares Out | 11.26% | |
| Short Percent Of Float | 11.79% | |
| Float Shares | 45.33M | |
| Shares Short Prior Month | 6.89M | |
| Average Daily Volume Last 10 Day | 3.03M | |
| Average Daily Volume In Three Month | 2.11M | |
| Date Short Interest | 15th of September 2021 |
Flexion Therapeutics Technical Analysis
Flexion Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Flexion Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Flexion Therapeutics. In general, you should focus on analyzing Flexion Stock price patterns and their correlations with different microeconomic environments and drivers.
Flexion Therapeutics Predictive Forecast Models
Flexion Therapeutics' time-series forecasting models is one of many Flexion Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Flexion Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Flexion Therapeutics
Checking the ongoing alerts about Flexion Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Flexion Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Flexion Therapeutics is not yet fully synchronised with the market data | |
| Flexion Therapeutics has some characteristics of a very speculative penny stock | |
| Flexion Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 102.74 M. Net Loss for the year was (95.05 M) with profit before overhead, payroll, taxes, and interest of 66.53 M. | |
| Flexion Therapeutics currently holds about 131.43 M in cash with (59.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.61. | |
| Over 92.0% of the company shares are owned by institutional investors |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Flexion Stock
If you are still planning to invest in Flexion Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Flexion Therapeutics' history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |